These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of in vitro activity of cefotaxime and desacetylcefotaxime alone and in combination against 320 gram-negative clinical isolates. Piédrola G, Galan I, Leyva A, Maroto MC. Drugs; 1988; 35 Suppl 2():62-4. PubMed ID: 3135171 [Abstract] [Full Text] [Related]
5. Potencies of ceftriaxone and cefotaxime in a single chamber pharmacokinetic system simulating their in vivo half-lives. Unowsky J, Sattler J, Patel IH. Chemotherapy; 1989; 35(5):338-44. PubMed ID: 2676404 [Abstract] [Full Text] [Related]
6. Bactericidal activity of ertapenem against major intra-abdominal pathogens. Borbone S, Cascone C, Santagati M, Mezzatesta ML, Stefani S. Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463 [Abstract] [Full Text] [Related]
8. [Comparison between the activity of 2 amino-glycoside antibiotics, tobramycin and gentamicin on gram negative bacteria in vitro]. De Rosa F, Tassi C, Stagni GR. Ann Sclavo; 1974 Nov; 16(1):65-72. PubMed ID: 4214247 [No Abstract] [Full Text] [Related]
11. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China. Yang Q, Zhang H, Cheng J, Xu Z, Xu Y, Cao B, Kong H, Ni Y, Yu Y, Sun Z, Hu B, Huang W, Wang Y, Wu A, Feng X, Liao K, Shen D, Hu Z, Chu Y, Lu J, Su J, Gui B, Duan Q, Zhang S, Shao H. Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890 [Abstract] [Full Text] [Related]
12. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit. Cordero L, Rau R, Taylor D, Ayers LW. Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611 [Abstract] [Full Text] [Related]